According to Genmab's latest financial reports the company's current earnings are HK$2.74 Billion. In 2023 the company made an earning of HK$6.26 Billion a decrease over its 2022 earnings that were of HK$7.53 Billion. The earnings displayed on this page is the company's Pretax Income.